Ver­san­t's lat­est biotech fo­cus­es on in­flam­ma­to­ry dis­eases

Ver­sant Ven­tures’ biotech in­cu­ba­tion team has launched an­oth­er Swiss start­up, this time fo­cused on a pair of an­ti­bod­ies for au­toim­mune and in­flam­ma­to­ry dis­eases.

Gran­ite Bio …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER